Terms: = Prostate cancer AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3
11 results:
1. Design, synthesis and antitumor activity of 2-substituted quinazoline-4-amine derivatives.
Wang M; Yu J; Huang X; Yu G; Liang Q; Cheng S; Meng X; Xu G; Li H; Luo H; Xu B
Bioorg Med Chem; 2024 Mar; 102():117660. PubMed ID: 38442524
[TBL] [Abstract] [Full Text] [Related]
2. Mechanism of Antitumor Effects of Saffron in Human prostate cancer Cells.
Khan M; Hearn K; Parry C; Rasid M; Brim H; Ashktorab H; Kwabi-Addo B
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201944
[TBL] [Abstract] [Full Text] [Related]
3. Fast robust optimization of proton PBS arc therapy plans using early energy layer selection and spot assignment.
Engwall E; Battinelli C; Wase V; Marthin O; Glimelius L; Bokrantz R; Andersson B; Fredriksson A
Phys Med Biol; 2022 Mar; 67(6):. PubMed ID: 35172282
[No Abstract] [Full Text] [Related]
4. Prevalence of APC and PTEN Alterations in Urachal cancer.
Nagy N; Reis H; Hadaschik B; Niedworok C; Módos O; Szendrői A; Bíró K; Hager T; Herold T; Ablat J; Black PC; Okon K; Tolkach Y; Csizmarik A; Oláh C; Keresztes D; Bremmer F; Gaisa NT; Kriegsmann J; Kovalszky I; Kiss A; Tímár J; Szász MA; Rink M; Fisch M; Nyirády P; Szarvas T
Pathol Oncol Res; 2020 Oct; 26(4):2773-2781. PubMed ID: 32754865
[TBL] [Abstract] [Full Text] [Related]
5. Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the wrn G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?
Febres-Aldana CA; Krishnamurthy K; Delgado R; Kochiyil J; Poppiti R; Medina AM
Pathol Res Pract; 2020 Feb; 216(2):152758. PubMed ID: 31831298
[TBL] [Abstract] [Full Text] [Related]
6. A comparison of two methods for expert elicitation in health technology assessments.
Grigore B; Peters J; Hyde C; Stein K
BMC Med Res Methodol; 2016 Jul; 16():85. PubMed ID: 27456844
[TBL] [Abstract] [Full Text] [Related]
7. Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.
Hart SN; Ellingson MS; Schahl K; Vedell PT; Carlson RE; Sinnwell JP; Barman P; Sicotte H; Eckel-Passow JE; Wang L; Kalari KR; Qin R; Kruisselbrink TM; Jimenez RE; Bryce AH; Tan W; Weinshilboum R; Wang L; Kohli M
BMJ Open; 2016 Apr; 6(4):e010332. PubMed ID: 27084275
[TBL] [Abstract] [Full Text] [Related]
8. Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer.
Valerio M; Anele C; Charman SC; van der Meulen J; Freeman A; Jameson C; Singh PB; Emberton M; Ahmed HU
BJU Int; 2016 Sep; 118(3):384-90. PubMed ID: 26332050
[TBL] [Abstract] [Full Text] [Related]
9. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
[TBL] [Abstract] [Full Text] [Related]
10. Single nucleotide polymorphism wrn Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects.
Wang L; Kaku H; Huang P; Xu K; Yang K; Zhang J; Li M; Xie L; Wang X; Sakai A; Watanabe M; Nasu Y; Shimizu K; Kumon H; Na Y
Acta Med Okayama; 2011 Oct; 65(5):315-23. PubMed ID: 22037268
[TBL] [Abstract] [Full Text] [Related]
11. Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
Gottipati P; Vischioni B; Schultz N; Solomons J; Bryant HE; Djureinovic T; Issaeva N; Sleeth K; Sharma RA; Helleday T
Cancer Res; 2010 Jul; 70(13):5389-98. PubMed ID: 20551068
[TBL] [Abstract] [Full Text] [Related]
